Banzai International (BNZI) PT Lowered to $23 at Ascendiant Capital

Ascendiant Capital analyst Edward Woo lowered the price target on Banzai International (NASDAQ: BNZI) to $23.00 (from $30.00) while maintaining a Buy rating.

The analyst comments "Reports Q3: Banzai recently (on November 14) reported its fiscal Q3 2025 (ending September) results. Revenue was $2.8 million (+163% y-o-y), compared to our estimates of $3.8 million and consensus of $3.7 million. Pro forma EPS was $(1.64), compared to our estimates of $(0.93).and consensus of $(0.50). There was no Q3 guidance. Strong Q3 revenue growth and ARR increase: Q3 2025 Annual Recurring Revenue (ARR) was $11 million, down from $12.6 million in Q2 2025 but +155% y-o-y. Q3 revenues were +163% y-o-y. No guidance: The company did not provide 2025 guidance."

You May Also Be Interested In

• Monopar Therapeutics (MNPR) PT Raised to $133 at BTIG
• Nomura/Instinet Upgrades Seiko Group Corp (8050:JP) to Buy
• Merit Medical Systems, Inc. (MMSI) PT Raised to $97 at BofA Securities